This is a preview of subscription content, log in via an institution to check access.
References
Perelson AS, Essunger P, Cao Y, et al. Decay characteristics of HIV-1 infected compartments during combination therapy. Nature 1997; 387: 188–91
Finzi D, Hermankova M, Pierson T, et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997; 278: 1295–300
Green S, Para MF, Daly PW, et al. Interim analysis of plasma viral burden and CD4 increases in HIV-1 infected patients with Rescriptor (DLV), Retrovir (ZDV) and Epivir (3TC) [abstract]. 12th World AIDS Conference, 1998 Jun 28–Jul 3; Geneva, 129
Montaner JSG, Reiss P, Cooper D, et al. A randomised, double-blinded trial comparing the immunologic and virologic effects of nevirapine, didanosine and zidovudine combinations among antiretroviral naive AIDS-free HIV-1 infected patients with CD4 cell counts between 200 and 600/mm3. JAMA 1998; 279: 930–7
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Conway, B. Efavirenz. Drugs 56, 1065–1066 (1998). https://doi.org/10.2165/00003495-199856060-00016
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199856060-00016